Fluorimetric determination of the enantiomers of vigabatrin, an antiepileptic drug, by reversed-phase HPLC with a novel diastereomer derivatization reagent.

2,5-dioxopyrrolidin-1-yl (4-{[(2-nitrophenyl)sulfonyl]oxy}-6-(3-oxomorpholino)quinoline-2-carbonyl)prolinate [Ns-MOK-(R)- or (S)-Pro-OSu] diastereomer derivatization fluorescence human serum vigabatrin enantiomers

Journal

Biomedical chromatography : BMC
ISSN: 1099-0801
Titre abrégé: Biomed Chromatogr
Pays: England
ID NLM: 8610241

Informations de publication

Date de publication:
May 2021
Historique:
revised: 21 12 2020
received: 29 09 2020
accepted: 21 12 2020
pubmed: 31 12 2020
medline: 10 7 2021
entrez: 30 12 2020
Statut: ppublish

Résumé

Herein, determination of an antiepileptic drug, (±)-vigabatrin (VB), was performed by reversed-phase HPLC with fluorimetric detection using a newly designed and synthesized fluorescence derivatization reagent, 2,5-dioxopyrrolidin-1-yl (4-{[(2-nitrophenyl)sulfonyl]oxy}-6-(3-oxomorpholino)quinoline-2-carbonyl)prolinate [Ns-MOK-(R)- or (S)-Pro-OSu]. During the derivatization of VB with Ns-MOK-(R)-Pro-OSu at 60°C, the nosyl (Ns) group, which was introduced to protect a phenolic hydroxy group, was released within 30 min to produce MOK-(R)-Pro-VB, which was detected fluorimetrically at 448 nm with an excitation wavelength of 333 nm. The VB enantiomers were separated on an octadecylsilica (ODS) column with a resolution value of 5.57, because Ns-MOK-(R)-Pro-OSu bears an optically active D-proline structure. A complete separation of MOK-(R)-Pro-(R)- and -(S)-VB enantiomers was achieved on the ODS column within 40 min using stepwise gradient elution, and the detection limits were ~0.80 and 0.37 pmol on the column, respectively. The proposed HPLC with fluorimetric detection method was successfully used for determining VB enantiomers in VB-spiked human serum following solid-phase extraction with an anion-exchange cartridge.

Identifiants

pubmed: 33377241
doi: 10.1002/bmc.5060
doi:

Substances chimiques

Anticonvulsants 0
Fluorescent Dyes 0
Indicators and Reagents 0
Vigabatrin GR120KRT6K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e5060

Informations de copyright

© 2020 John Wiley & Sons, Ltd.

Références

Al-Kindy, S., Santa, T., Fukushima, T., Homma, H., & Imai, K. (1998). Enantiomeric determination of amines by high-performance liquid chromatography using chiral fluorescent derivatization reagents. Biomedical Chromatography, 12, 276-280. https://doi.org/10.1002/(sici)1099-0801(199809/10)12:5<276::aid-bmc747>3.0.co;2-y
Al-Majed, A. A. (2009). A direct HPLC method for the resolution and quantitation of the R-(−)- and S-(+)-enantiomers of vigabatrin (gamma-vinyl-GABA) in pharmaceutical dosage forms using teicoplanin aglycone chiral stationary phase. Journal of Pharmaceutical and Biomedical Analysis, 50, 96-99. https://doi.org/10.1016/j.jpba.2009.03.030
Duhamel, P., Ounissi, M., Le Saux, T., Bienayme, H., Chiron, C., & Jullien, V. (2017). Determination of the R(−) and S(+)-enantiomers of vigabatrin in human plasma by ultra-high-performance liquid chromatography and tandem mass-spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1070, 31-36. https://doi.org/10.1016/j.jchromb.2017.10.037
Fueloep, F., Szatmari, I., Vamos, E., Zadori, D., Toldi, J., & Vecsei, L. (2009). Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives. Current Medicinal Chemistry, 16, 4828-4842. https://doi.org/10.2174/092986709789909602
Fukushima, T., Mitsuhashi, S., Tomiya, M., Iyo, M., Hashimoto, K., & Toyo'oka, T. (2007). Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. Clinica Chimica Acta, 377, 174-178. https://doi.org/10.1016/j.cca.2006.09.019
Hsieh, C. Y., Wang, S. Y., Kwan, A. L., & Wu, H. L. (2008). Fluorescent high-performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride. Journal of Chromatography A, 1178, 166-170. https://doi.org/10.1016/j.chroma.2007.11.096
Ishii, K., Ogaya, T., Song, Z., Iizuka, H., & Fukushima, T. (2010). Changes in the plasma concentrations of d-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers. Chirality, 22, 901-906. https://doi.org/10.1002/chir.20850
Iwasaki, M., Kashiwaguma, Y., Nagashima, C., Izumi, M., Uekusa, A., Iwasa, S., … Fukushima, T. (2016). A high-performance liquid chromatography assay with a triazole-bonded column for evaluation of d-amino acid oxidase activity. Biomedical Chromatography, 30, 384-389. https://doi.org/10.1002/bmc.3559
Jin, D. R., Nagakura, K., Murofushi, S., Miyahara, T., & Toyo'oka, T. (1998). Total resolution of 17 dl-amino acids labelled with a fluorescent chiral reagent, R(−)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole, by high-performance liquid chromatography. Journal of Chromatography a, 822, 215-224. https://doi.org/10.1016/s0021-9673(98)00617-7
Kan, T., & Fukuyama, T. (2001). Highly versatile synthesis of nitrogen-containing compounds by means of nitrobenzenesulfonamides. Journal of Synthetic Organic Chemistry, Japan, 59, 779-789. https://doi.org/10.5059/yukigoseikyokaishi.59.779
Kan, T., & Fukuyama, T. (2004). Ns strategies: A highly versatile synthetic method for amines. Chemical Communications, 353-359. https://doi.org/10.1039/b311203a
Kondo, J., Imaoka, T., Suzuki, N., Kawasaki, T., Nakanishi, A., & Kawahara, Y. (1994). N-4-(6-Methoxy-2-benzoxazolyl) benzoyl-l-amino acids as chiral derivatization reagents for amine enantiomers. Analytical Sciences, 10, 697-703. https://doi.org/10.2116/analsci.10.697
Ounissi, M., Rodrigues, C., Bienayme, H., Duhamel, P., Pons, G., Dulac, O., … Jullien, V. (2019). Proposition of a minimal effective dose of vigabatrin for the treatment of infantile spasms using pediatric and adult pharmacokinetic data. Journal of Clinical Pharmacology, 59, 177-188. https://doi.org/10.1002/jcph.1309
Rey, E., Pons, G., & Olive, G. (1992). Vigabatrin-Clinical pharmacokinetics. Clinical Pharmacokinetics, 23, 267-278. https://doi.org/10.2165/00003088-199223040-00003
Rey, E., Pons, G., Richard, M. O., Vauzelle, F., Dathis, P., Chiron, C., … Olive, G. (1990). Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl gaba) in epileptic children. British Journal of Clinical Pharmacology, 30, 253-257. https://doi.org/10.1111/j.1365-2125.1990.tb03772.x
Sakamoto, T., Furukawa, S., Nishizawa, T., Fukuda, M., Sasaki, M., Onozato, M., … Fukushima, T. (2019). Succinimidyl (3-(benzyloxy)carbonyl-5-oxo-1,3-oxazolidin-4-yl)acetate on a triazole-bonded phase for the separation of dl-amino-acid enantiomers and the mass-spectrometric determination of chiral amino acids in rat plasma. Journal of Chromatography A, 1585, 131-137. https://doi.org/10.1016/j.chroma.2018.11.061
Silverman, R. B. (2018). Design and mechanism of GABA aminotransferase inactivators. Treatments for epilepsies and addictions. Chemical Reviews, 118, 4037-4070. https://doi.org/10.1021/acs.chemrev.8b00009
Takahashi, S., Iizuka, H., Kuwabara, R., Naito, Y., Sakamoto, T., Miyagi, A., … Fukushima, T. (2016). Determination of l-tryptophan and l-kynurenine derivatized with (R)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2, 1,3-benzoxadiazole by LC-MS/MS on a triazole-bonded column and their quantification in human serum. Biomedical Chromatography, 30, 1481-1486. https://doi.org/10.1002/bmc.3709
Toyo'oka, T., Liu, Y. M., Hanioka, N., Jinno, H., & Ando, M. (1994). Determination of alcohols and amines, labeled with 4-(N,N-dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-be nzoxadiazole by liquid-chromatography with conventional and laser-induced fluorescence detection. Analytica Chimica Acta, 285, 343-351. https://doi.org/10.1016/0003-2670(94)80074-x
Toyo'oka, T., Liu, Y. M., Hanioka, N., Jinno, H., Ando, M., & Imai, K. (1994a). Resolution of enantiomers of alcohols and amines by high-performance liquid-chromatography after derivatization with a novel fluorescent chiral reagent. Journal of Chromatography a, 675, 79-88. https://doi.org/10.1016/0021-9673(94)85262-6
Toyo'oka, T., Liu, Y. M., Jinno, H., Hanioka, N., Ando, M., & Imai, K. (1994b). Chiral separation of amines by high-performance liquid-chromatography after tagging with 4-(N,N-dimethylaminosulphonyl)-7-(2-chloroformylpyrrolidin-1-yl)- 2,1,3-benzoxadiazole. Biomedical Chromatography, 8, 85-89. https://doi.org/10.1002/bmc.1130080208
Uchiyama, S., Santa, T., & Imai, K. (1999). Fluorescence characteristics of six 4,7-disubstituted benzofurazan compounds: An experimental and semi-empirical MO study. Journal of the Chemical Society, Perkin Transactions, 2, 2525-2532. https://doi.org/10.1039/a904989d
Zhao, J., Shin, Y., Jin, Y., Jeong, K. M., & Lee, J. (2017). Determination of enantiomeric vigabatrin by derivatization with diacetyl-l-tartaric anhydride followed by ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1040, 199-207. https://doi.org/10.1016/j.jchromb.2016.11.016

Auteurs

Shusuke Uekusa (S)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Mayu Onozato (M)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Tatsuya Sakamoto (T)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Maho Umino (M)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Hideaki Ichiba (H)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Takeshi Fukushima (T)

Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH